Orum Therapeutics
₩15,270
1
-₩140-0.91% 01:27 Today
Statistics
Day High
15,510
Day Low
14,820
52W High
143,700
52W Low
15,190
Volume
8,735,428
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Orum Therapeutics, Inc. is a biopharmaceutical company dedicated to the discovery and development of novel therapeutic solutions for both cancer and immune system conditions. The firm specializes in creating degrader-antibody conjugates, an innovative class of drugs that merges traditional antibody-drug conjugate (ADC) technology with targeted protein degradation. Their flagship product candidate, ORM-1153, functions as a GSPT1 protein degrader, specifically engineered to address hematologic malignancies. Orum Therapeutics was established in 2016 and operates out of Daejeon, South Korea.
Show More
CEO
Sung-Joo Lee
Employees
21
Country
South Korea
ISIN
KR7475830006
Listings
0 Comments
Share your thoughts
FAQs
What is Orum Therapeutics stock price today?▼
The current price of 475830.KQ is ₩15,270 KRW — it has decreased by -0.91% in the past 24 hours. Watch Orum Therapeutics stock price performance more closely on the chart.
What is Orum Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Orum Therapeutics stocks are traded under the ticker 475830.KQ.
Is Orum Therapeutics stock price growing?▼
475830.KQ stock has fallen by -5.1% compared to the previous week, the month change is a -27.9% fall, over the last year Orum Therapeutics has showed a -69.35% decrease.
How many employees does Orum Therapeutics have?▼
As of November 3, 2026, the company has 21 employees.
In which sector is Orum Therapeutics located?▼
Orum Therapeutics operates in the Health & Wellness sector.
When did Orum Therapeutics complete a stock split?▼
Orum Therapeutics has not had any recent stock splits.
Where is Orum Therapeutics headquartered?▼
Orum Therapeutics is headquartered in Daejeon, South Korea.